ENFR

Arseus and Waterland Private Equity Investments

November 2009

Waterland Private Equity Investments (Netherlands) has acquired Omega Pharma’s interest in Arseus NV (Belgium). Arseus’s main entity, Fagron, is the European leader in pharmaceutical compounding and has operations in Europe, the US and Brazil.

Ohana & Co. acted as the exclusive financial advisor to Arseus.

Related Transactions

After a competitive process orchestrated by Ohana & Co., Interparfums has entered into an agreement with The Procter & Gamble Company (P&G), the world’s largest fast-moving consumer good (FMCG) groups with sales of over $80 billion dollars, to acquire the Rochas brand for $108 million. Founded in 1925 by Marcel Rochas, the brand began as a fashion house and expanded into a perfumery in the 1950s under Hélène Rochas’s direction. Rochas is one the oldest and most iconic French luxury fashion houses. The brand stands for the quintessence of Parisian chic, with a unique couture and haute perfumery heritage and sense of craftsmanship. The house currently enjoys worldwide brand awareness, with products sold in more than 40 countries. Ohana & Co. acted as the exclusive financial advisor to Procter & Gamble.

Read more

LVMH group, the world leader in luxury goods, has acquired a minority equity interest in Assouline, a publisher of luxury illustrated books, to support the company’s international expansion. Ohana & Co. acted as the exclusive financial advisor to Assouline and its shareholders.  

Read more

AREVA (EPA: AREVA), the France-based global leader in nuclear energy with 2015 sales of $4.6 billion, has sold its wholly owned US subsidiary, Canberra Industries, the leading provider of innovative nuclear measurement solutions, to California-based Mirion Technologies, a global leader in radiation detection and protection, backed by private equity fund Charterhouse Capital. Canberra Industries, based in Meriden, Connecticut, is a leader in the nuclear measurement sector. It designs, manufactures and markets innovative and cost-effective nuclear measurement solutions used to maintain safety of personnel, assess the health of nuclear facilities and safeguard the public and the environment. Canberra generated revenues of about $200 million in 2014 and has more than a thousand employees worldwide. In this competitive process initiated by Areva in June 2015, Ohana & Co. acted as global advisor to Canberra’s management team, accompanying it throughout the entire process. Ohana & Co. assisted the management team on the structuring of its exit package, the preparation of the roadshow with the various bidders and the negotiation of equity investment packages with each of the bidders shortlisted by Areva.

Read more